1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Goodfellow, B.J.
Dias, J.S.
Ferreira, G.C.
Wray, V.
Henklein, P.
Macedo, A.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
505
325
10.1016/S0014-5793(01)02818-6
11566198
The Solution Structure and Heme Binding of the Presequence of Murine 5-Aminolevulinate Synthase
2001
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2586.189
AMINOLEVULINIC ACID SYNTHASE 2, ERYTHROID
2.3.1.37
PRESEQUENCE RESIDUES 1-26
1
syn
polymer
AMINO LEVULINATE SYNTHASE, 5-AMINOLEVULINIC ACID SYNTHASE, DELTA-AMINOLEVULINATE SYNTHASE, DELTA-ALA SYNTHETASE
no
no
MVAAAMLLRSCPVLSQGPTGLLGKVA
MVAAAMLLRSCPVLSQGPTGLLGKVA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
1
0
2001-10-18
1
1
2011-05-08
1
2
2011-07-13
PDBE
Y
PDBE
2001-07-08
REL
10090
MUS MUSCULUS
sample
150MS NOESY, 70MS TOCSY
LOW TARGET FUNCTION
20
15
NOESY
COSY
TOCSY
5
pH
303
K
torsion angle dynamics
1
GUNTERT,WUTHRICH
refinement
DYANA
structure solution
DYANA
600
Bruker
DMX
MET
1
n
1
MET
1
A
VAL
2
n
2
VAL
2
A
ALA
3
n
3
ALA
3
A
ALA
4
n
4
ALA
4
A
ALA
5
n
5
ALA
5
A
MET
6
n
6
MET
6
A
LEU
7
n
7
LEU
7
A
LEU
8
n
8
LEU
8
A
ARG
9
n
9
ARG
9
A
SER
10
n
10
SER
10
A
CYS
11
n
11
CYS
11
A
PRO
12
n
12
PRO
12
A
VAL
13
n
13
VAL
13
A
LEU
14
n
14
LEU
14
A
SER
15
n
15
SER
15
A
GLN
16
n
16
GLN
16
A
GLY
17
n
17
GLY
17
A
PRO
18
n
18
PRO
18
A
THR
19
n
19
THR
19
A
GLY
20
n
20
GLY
20
A
LEU
21
n
21
LEU
21
A
LEU
22
n
22
LEU
22
A
GLY
23
n
23
GLY
23
A
LYS
24
n
24
LYS
24
A
VAL
25
n
25
VAL
25
A
ALA
26
n
26
ALA
26
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
6
A
A
O
OXT
LEU
ALA
22
26
2.08
9
A
A
O
H
LEU
LYS
21
24
1.54
1
A
VAL
2
-164.62
-157.62
1
A
LEU
8
-91.31
48.33
1
A
ARG
9
-58.60
-92.12
1
A
GLN
16
69.28
64.76
1
A
THR
19
80.29
-57.45
2
A
ALA
3
-110.57
59.43
2
A
ALA
5
-159.63
-45.24
2
A
MET
6
-88.82
40.32
2
A
LEU
7
-154.48
-47.72
2
A
PRO
12
-75.06
-84.28
2
A
LEU
14
-178.94
97.40
2
A
LYS
24
-117.40
52.37
3
A
ALA
4
-144.80
-48.22
3
A
MET
6
-37.77
-36.92
3
A
LEU
7
-94.73
-61.33
3
A
LEU
8
38.54
64.81
3
A
SER
10
-176.72
59.87
3
A
VAL
13
-125.32
-95.20
3
A
GLN
16
-119.07
65.01
3
A
THR
19
167.04
-31.11
3
A
LYS
24
-155.86
78.36
4
A
ALA
3
-141.09
54.17
4
A
ALA
4
-64.25
-72.93
4
A
LEU
8
-143.73
49.46
4
A
SER
10
43.48
28.00
4
A
CYS
11
46.96
88.90
4
A
LEU
14
-173.35
-62.17
4
A
PRO
18
-75.05
-70.57
4
A
THR
19
167.79
-39.37
4
A
LEU
21
-136.50
-54.17
4
A
LYS
24
-166.27
83.60
5
A
VAL
2
-166.56
-157.58
5
A
ALA
3
-106.41
47.89
5
A
ALA
4
-147.15
58.96
5
A
ALA
5
-157.30
-47.09
5
A
MET
6
-88.49
38.77
5
A
LEU
7
-151.27
-47.15
5
A
LEU
8
-117.90
60.24
5
A
CYS
11
39.18
65.06
5
A
VAL
13
-158.89
-45.20
5
A
LEU
14
77.75
-56.19
5
A
SER
15
176.50
-60.09
5
A
LEU
21
-91.27
49.64
6
A
ALA
3
-161.34
58.37
6
A
PRO
12
-75.01
-72.25
6
A
LEU
14
-174.28
-67.53
6
A
SER
15
-173.72
-57.38
6
A
THR
19
38.81
76.80
6
A
VAL
25
-105.72
-107.70
7
A
ALA
4
40.45
29.85
7
A
ALA
5
-160.31
-47.98
7
A
LEU
8
51.25
81.82
7
A
SER
10
169.78
41.37
7
A
CYS
11
43.20
76.65
7
A
LEU
14
52.10
94.77
7
A
THR
19
80.39
-52.71
7
A
VAL
25
-108.81
-107.93
8
A
VAL
2
-170.36
-157.61
8
A
ALA
3
-98.22
53.08
8
A
ALA
4
-109.85
59.81
8
A
ALA
5
-165.18
-43.71
8
A
MET
6
-89.09
37.26
8
A
LEU
7
-149.21
-48.64
8
A
LEU
8
-105.69
49.80
8
A
SER
10
-140.46
55.92
8
A
LEU
14
56.74
89.73
8
A
THR
19
80.01
-53.31
8
A
LEU
22
-122.00
-97.31
8
A
VAL
25
-105.51
-107.62
9
A
VAL
2
-95.77
-156.74
9
A
LEU
8
-87.90
46.44
9
A
CYS
11
63.11
151.28
9
A
SER
15
58.68
158.67
9
A
VAL
25
-103.29
-107.40
10
A
ALA
3
-108.29
60.15
10
A
LEU
8
-150.06
-52.22
10
A
LEU
21
-150.72
-67.04
10
A
LYS
24
-96.53
33.13
10
A
VAL
25
-123.12
-107.95
11
A
ALA
3
-111.87
68.65
11
A
ALA
4
-159.41
39.38
11
A
ALA
5
-133.75
-47.15
11
A
MET
6
-88.38
39.34
11
A
LEU
7
-160.36
-45.51
11
A
SER
10
-169.01
67.01
11
A
VAL
13
-140.64
-95.18
11
A
LEU
14
77.75
-56.29
11
A
GLN
16
65.19
161.41
11
A
VAL
25
-103.37
-107.33
12
A
ALA
4
-177.24
52.28
12
A
ALA
5
-172.41
-49.80
12
A
LEU
8
-92.47
44.10
12
A
GLN
16
-167.47
72.70
12
A
LEU
22
-165.16
32.37
12
A
LYS
24
-99.64
32.24
12
A
VAL
25
-103.41
-107.36
13
A
ALA
4
178.62
55.02
13
A
ALA
5
178.75
-52.00
13
A
LEU
8
-100.28
51.33
13
A
SER
10
-143.91
-58.51
13
A
LEU
14
-174.89
-53.48
13
A
SER
15
-179.85
136.04
13
A
GLN
16
64.47
139.67
13
A
PRO
18
-75.00
-70.36
13
A
THR
19
167.05
-80.90
13
A
LEU
22
68.09
-96.69
13
A
VAL
25
-115.91
-107.89
14
A
ALA
4
-135.63
-47.41
14
A
ALA
5
-91.26
40.91
14
A
ARG
9
-93.89
38.53
14
A
CYS
11
44.00
81.35
14
A
LEU
14
62.36
77.59
14
A
PRO
18
-75.01
-70.34
14
A
THR
19
167.84
-37.83
14
A
LEU
21
-120.09
-58.34
14
A
LYS
24
-159.86
80.76
14
A
VAL
25
-103.32
-107.35
15
A
ALA
4
-126.95
-53.16
15
A
LEU
8
-111.41
56.40
15
A
SER
10
48.11
24.19
15
A
CYS
11
63.30
151.02
15
A
VAL
13
-136.65
-95.20
15
A
THR
19
38.96
74.59
15
A
LEU
21
-124.51
-68.96
15
A
LEU
22
-40.58
104.56
15
A
VAL
25
-103.41
-107.39
AMINOLEVULINIC ACID SYNTHASE 2, ERYTHROID (E.C.2.3.1.37)
Solution structure of the 26 aa presequence of 5-ALAS
1
N
N
ACYLTRANSFERASE
ACYLTRANSFERASE, ALAS, PRESEQUENCE
Q64452
UNP
1
Q64452
1
26
1H7J
1
26
Q64452
A
1
1
26
1
P 1